Ptak W, Paliwal V, Bryniarski K, Ptak M, Askenase P W
Department of Immunology, College of Medicine, Jagiellonian University, Cracow, Poland.
Scand J Immunol. 1998 Feb;47(2):136-45. doi: 10.1046/j.1365-3083.1998.00264.x.
We determined the regulatory properties of heat-aggregated immunoglobulins (HA-Ig) that possess many activities of immune complexes (IC), such as binding and activation of cells via immunoglobulin Fc gamma receptors (FcgammaR). HA-Ig protected contact sensitivity (CS) effector T cells from antigen-specific immunosuppression, while monomeric IgG were inactive. This anti-suppressive activity of HA-Ig was antigen non-specific, and depended on the species from which Ig was derived, i.e. mouse and rat HA-Ig were protective in mice, and of other species were inactive. The protecting activity of HA-Ig was confined to IgG2a and IgG3, and to a lesser degree to IgG1 isotypes, and resided in the Fc domain. Removal of phagocytic cells from the CS-immune target cells, or blocking with anti-FcgammaR mAb, abolished HA-Ig protection of CS-effector T cells from suppression. We suggest that HA-Ig multimers acted via Fc domains, in one of two ways: by binding to FcgammaR of macrophages to produce positive-acting cytokines, or by blocking FcgammaR on macrophages, to compete with suppressive factors that can also bind to FcgammaR. If HA-Ig protection of T cells is generalized, it is likely that IC in vivo may non-specifically overcome suppression of responses to antigen that normally are under the control of T suppressive cells, and thus may contribute to the development of autoimmunity.
我们确定了热聚集免疫球蛋白(HA-Ig)的调节特性,其具有许多免疫复合物(IC)的活性,如通过免疫球蛋白Fcγ受体(FcgammaR)结合并激活细胞。HA-Ig保护接触敏感性(CS)效应T细胞免受抗原特异性免疫抑制,而单体IgG则无活性。HA-Ig的这种抗抑制活性是非抗原特异性的,并且取决于Ig来源的物种,即小鼠和大鼠的HA-Ig在小鼠中具有保护作用,而其他物种的则无活性。HA-Ig的保护活性仅限于IgG2a和IgG3,在较小程度上也包括IgG1同种型,并且存在于Fc结构域中。从CS免疫靶细胞中去除吞噬细胞,或用抗FcgammaR单克隆抗体阻断,可消除HA-Ig对CS效应T细胞的抑制保护作用。我们认为,HA-Ig多聚体通过Fc结构域以两种方式之一发挥作用:通过与巨噬细胞的FcgammaR结合产生正性作用的细胞因子,或通过阻断巨噬细胞上的FcgammaR,与也可结合FcgammaR的抑制因子竞争。如果HA-Ig对T细胞的保护作用具有普遍性,那么体内的IC可能会非特异性地克服通常受T抑制细胞控制的对抗原反应的抑制,从而可能有助于自身免疫的发展。